chr17-48544649-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002145.4(HOXB2):c.263C>T(p.Ala88Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000158 in 1,459,390 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002145.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HOXB2 | NM_002145.4 | c.263C>T | p.Ala88Val | missense_variant | 1/2 | ENST00000330070.6 | |
HOXB-AS1 | NR_102279.1 | n.62+237G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HOXB2 | ENST00000330070.6 | c.263C>T | p.Ala88Val | missense_variant | 1/2 | 1 | NM_002145.4 | P1 | |
HOXB-AS1 | ENST00000435312.5 | n.62+237G>A | intron_variant, non_coding_transcript_variant | 5 | |||||
HOXB-AS1 | ENST00000504972.3 | n.88-846G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000826 AC: 2AN: 242056Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132176
GnomAD4 exome AF: 0.0000158 AC: 23AN: 1459390Hom.: 2 Cov.: 38 AF XY: 0.0000152 AC XY: 11AN XY: 725904
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.263C>T (p.A88V) alteration is located in exon 1 (coding exon 1) of the HOXB2 gene. This alteration results from a C to T substitution at nucleotide position 263, causing the alanine (A) at amino acid position 88 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at